Active Ingredient(s): Rifamycin
FDA Approved: * November 16, 2018
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aemcolo Overview

The rifamycins are a group of antibiotics that are synthesized either naturally by the bacterium Amycolatopsis rifamycinica or artificially. They are a subclass of the larger family of ansamycins. Rifamycins are particularly effective against mycobacteria, and are therefore used to treat tuberculosis, leprosy, and mycobacterium avium complex (MAC) infections. The rifamycin group includes the "classic" rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, r...

Read more Aemcolo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Aemcolo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet, Delayed Release: 194mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aemcolo: (3 results)

Sorted by National Drug Code
  • 57841-1200 Aemcolo 194 mg Oral Tablet, Delayed Release by Redhill Biopharma Ltd
  • 57841-1201 Aemcolo 194 mg Oral Tablet, Delayed Release by Redhill Biopharma Ltd
  • 71068-001 Aemcolo 194 mg Oral Tablet, Delayed Release by Aries Pharmaceuticals Inc

Other drugs which contain Rifamycin or a similar ingredient: (2 results)